Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400) | American Lung Association

This website uses cookies. By continuing you are agreeing to our privacy policy.

Clinical Trials

Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400)

Institution:

The study is being conducted at hundreds of sites in the United States. A full list of sites at which Lung-MAP is currently being conducted is available on the website

Type:

Multi-Center Trial

Purpose:

Squamous cell lung cancer. Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.

Dates:

June 16, 2014 - January 1, 2022

Disease:

Lung Cancer

Register:

http://www.lung-map.org/locations

Watch the video to learn more about the Lung-MAP trial.

Blank Section Header
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.